Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Index- P/E- EPS (ttm)-1.13 Insider Own0.41% Shs Outstand136.41M Perf Week7.39%
Market Cap3.73B Forward P/E8.79 EPS next Y3.11 Insider Trans-9.09% Shs Float135.86M Perf Month11.65%
Income-154.90M PEG- EPS next Q0.95 Inst Own94.72% Short Float4.03% Perf Quarter-2.15%
Sales4.39B P/S0.85 EPS this Y0.54% Inst Trans-3.59% Short Ratio4.06 Perf Half Y-12.21%
Book/sh33.45 P/B0.82 EPS next Y19.74% ROA-1.34% Short Interest5.47M Perf Year-4.07%
Cash/sh10.73 P/C2.55 EPS next 5Y10.00% ROE-3.16% 52W Range23.89 - 34.60 Perf YTD-15.13%
Dividend Est.1.10 (4.03%) P/FCF27.13 EPS past 5Y- ROI-1.74% 52W High-21.07% Beta0.50
Dividend TTM1.10 (4.03%) Quick Ratio1.77 Sales past 5Y0.02% Gross Margin41.75% 52W Low14.30% ATR (14)0.75
Dividend Ex-DateNov 29, 2024 Current Ratio2.56 EPS Y/Y TTM-22742.00% Oper. Margin6.51% RSI (14)62.63 Volatility3.45% 2.70%
Employees9140 Debt/Eq1.04 Sales Y/Y TTM-5.60% Profit Margin-3.53% Recom1.43 Target Price36.00
Option/ShortYes / Yes LT Debt/Eq0.94 EPS Q/Q-235.73% Payout- Rel Volume2.63 Prev Close25.35
Sales Surprise-3.08% EPS Surprise-0.18% Sales Q/Q-3.23% EarningsNov 06 BMO Avg Volume1.35M Price27.31
SMA207.87% SMA504.13% SMA200-4.45% Trades Volume3,627,507 Change7.73%
Date Action Analyst Rating Change Price Target Change
Sep-24-24Resumed Jefferies Hold $50 → $30
Nov-17-23Initiated Piper Sandler Overweight $37
Mar-07-23Initiated Canaccord Genuity Buy $49
Sep-14-22Upgrade Argus Hold → Buy $46
Sep-06-22Upgrade Wells Fargo Equal Weight → Overweight $48 → $54
Oct-14-21Upgrade Raymond James Mkt Perform → Outperform $59
Sep-30-21Upgrade Jefferies Hold → Buy $45 → $63
Apr-07-21Resumed RBC Capital Mkts Sector Perform $51
Jan-06-21Downgrade RBC Capital Mkts Outperform → Sector Perform $59 → $49
Apr-17-20Downgrade Argus Buy → Hold
Today 02:09AM
Nov-06-24 04:51PM
09:51AM
09:51AM
09:30AM
07:40AM Loading…
07:40AM
06:47AM
Nov-01-24 02:57PM
Oct-30-24 10:01AM
Oct-23-24 10:37AM
09:00AM
Oct-15-24 08:00AM
Sep-26-24 08:30AM
Sep-17-24 04:48PM
Sep-13-24 07:00PM
09:00AM Loading…
Sep-12-24 09:00AM
06:52AM
Sep-05-24 01:07AM
Sep-04-24 08:00AM
Sep-02-24 06:05PM
Aug-27-24 08:30AM
Aug-19-24 08:30AM
Aug-14-24 06:00AM
Aug-09-24 06:21AM
Aug-05-24 09:15AM
Aug-02-24 02:16PM
10:42AM
09:30AM
07:54AM
07:45AM
06:43AM Loading…
06:43AM
06:31AM
Aug-01-24 09:00AM
Jul-31-24 09:30AM
Jul-29-24 12:10PM
Jul-26-24 10:00AM
Jul-23-24 06:59AM
Jul-19-24 09:15AM
Jul-10-24 08:00AM
Jun-06-24 11:31AM
May-30-24 11:28AM
May-28-24 08:03AM
May-13-24 11:53AM
10:11AM
May-07-24 04:31PM
11:23AM
10:53AM
09:30AM
08:28AM
08:02AM
06:51AM
06:40AM
06:31AM
06:28AM
May-06-24 09:16AM
May-01-24 09:42AM
Apr-30-24 10:59AM
Apr-25-24 10:41AM
06:00AM
Apr-23-24 08:09AM
Apr-15-24 08:15AM
Apr-11-24 09:03AM
Apr-09-24 12:30PM
Apr-04-24 04:37PM
Mar-28-24 11:30AM
Mar-18-24 10:00AM
Mar-05-24 10:48AM
Mar-04-24 11:23AM
08:00AM
08:00AM
Mar-03-24 10:32AM
Feb-29-24 04:21PM
Feb-28-24 06:13AM
Feb-27-24 12:32PM
09:30AM
07:12AM
06:49AM
06:48AM
06:30AM
Feb-26-24 04:30PM
09:16AM
Feb-20-24 01:32PM
Feb-13-24 08:16AM
Dec-07-23 11:31AM
Nov-29-23 08:54AM
Nov-28-23 01:04PM
Nov-16-23 05:16AM
Nov-15-23 05:03AM
Nov-10-23 09:16AM
Nov-08-23 02:38PM
Nov-07-23 02:16PM
11:53AM
09:30AM
08:56AM
07:10AM
06:47AM
06:30AM
Nov-02-23 01:39PM
Oct-31-23 11:27AM
08:54AM
Perrigo Co. Plc engages in the provision of self-care products and over the counter health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. It operates through the Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment offers OTC solutions, infant formula, oral care, and contract manufacturing in the U.S, Mexico, and Canada. The Consumer Self-Care International segment includes the self-care business branded in Europe, Australia, the United Kingdom, and parts of Europe and Asia. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schmelter TrionaEVP & President CSCAOct 04 '24Option Exercise24.933,61190,0223,141Oct 17 05:00 PM
Doyle Katherine C.DirectorSep 13 '24Sale27.308,954244,4446,009Sep 13 03:28 PM
Doyle Katherine C.DirectorSep 13 '24Proposed Sale27.308,954244,444Sep 13 10:03 AM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOAug 26 '24Sale29.4013,000382,24620,553Aug 28 05:17 PM
RONALD CRAIG JANISHInsider / Exec VP of Global OpAug 26 '24Proposed Sale29.4013,000382,246Aug 26 04:07 PM
Andersen SvendEVP & President CHCIAug 20 '24Sale27.7528,300785,27973,553Aug 21 09:20 AM
Andersen SvendEVP & President CHCIAug 20 '24Sale27.436,683183,2817,000Aug 21 09:20 AM
Andersen SvendOfficerAug 20 '24Proposed Sale27.8620,500571,130Aug 20 01:09 PM
HANSON KYLEOfficerAug 07 '24Proposed Sale28.401,89053,667Aug 07 12:02 PM
Lockwood-Taylor PatrickCEOJul 10 '24Option Exercise27.1628,326769,33448,826Jul 11 12:34 PM
Ives AlisonEVP & Chief Scientific OfficerJul 08 '24Option Exercise25.7292023,66218,930Jul 10 09:51 AM
Bezerra Eduardo GuaritaEVP & Chief Financial OfficerJun 07 '24Option Exercise26.944,532122,09216,563Jun 11 01:44 PM
Andersen SvendEVP & President CHCIMay 28 '24Buy27.901,00027,900101,853May 31 05:04 PM
Parker Geoffrey M.DirectorMay 15 '24Option Exercise30.228,764264,84824,469May 16 07:28 PM
O'Connor DonalDirectorMay 15 '24Option Exercise30.228,764264,84829,694May 16 07:28 PM
Doyle Katherine C.DirectorMay 15 '24Option Exercise30.228,764264,84819,170May 16 07:27 PM
ASHFORD ORLANDO DDirectorMay 15 '24Option Exercise30.2210,955331,06020,992May 16 07:27 PM
Alford Bradley ADirectorMay 15 '24Option Exercise30.228,764264,84840,217May 16 07:27 PM
Karaboutis AdrianaDirectorMay 15 '24Option Exercise30.228,764264,84826,686May 16 07:26 PM
Manzone AlbertDirectorMay 15 '24Option Exercise30.228,764264,84811,612May 16 07:26 PM
KINDLER JEFFREY BDirectorMay 15 '24Option Exercise30.228,764264,84827,214May 16 07:26 PM
Mann Erica LDirectorMay 15 '24Option Exercise30.228,764264,84821,665May 16 07:26 PM
Quinn GrainneEVP, Chief Medical OfficerMar 07 '24Option Exercise29.692,24966,77322,248Mar 08 09:57 PM
Quinn GrainneEVP, Chief Medical OfficerMar 06 '24Option Exercise28.091,75949,41020,914Mar 08 09:57 PM
Willis RobertEVP & CHROMar 07 '24Option Exercise29.692,16364,21932,595Mar 08 09:34 PM
Willis RobertEVP & CHROMar 06 '24Option Exercise28.091,75949,41031,347Mar 08 09:34 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 07 '24Option Exercise29.692,94287,34834,439Mar 08 09:18 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 06 '24Option Exercise28.092,30064,60732,190Mar 08 09:18 PM
HANSON KYLEEVP & General CounselMar 06 '24Option Exercise28.093,51898,82112,284Mar 08 08:52 PM
Farrington ThomasEVP and CIOMar 06 '24Option Exercise28.091,88152,83711,389Mar 08 08:17 PM
Bezerra Eduardo GuaritaEVP & Chief Financial OfficerMar 06 '24Option Exercise28.094,870136,79813,298Mar 08 07:51 PM
Ives AlisonEVP & Chief Scientific OfficerMar 06 '24Option Exercise28.092,03057,02317,402Mar 08 07:36 PM
Ives AlisonEVP & Chief Scientific OfficerMar 07 '24Option Exercise29.691,74651,83918,536Mar 08 07:36 PM
Andersen SvendEVP & President CHCIMar 07 '24Option Exercise29.695,468162,345100,853Mar 08 07:18 PM
Andersen SvendEVP & President CHCIMar 06 '24Option Exercise28.093,788106,40595,385Mar 08 07:18 PM
Ives AlisonEVP & Chief Scientific OfficerMar 05 '24Option Exercise27.261,69846,28714,144Mar 07 09:58 PM
Ives AlisonEVP & Chief Scientific OfficerMar 05 '24Buy27.262,49067,87716,122Mar 07 09:58 PM
Ives AlisonEVP & Chief Scientific OfficerFeb 29 '24Buy26.441,54540,85012,446Mar 07 09:54 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 05 '24Option Exercise27.262,07156,45522,262Mar 07 09:28 PM
Willis RobertEVP & CHROMar 05 '24Option Exercise27.261,27934,86626,755Mar 07 09:10 PM
Quinn GrainneEVP, Chief Medical OfficerMar 05 '24Option Exercise27.261,58343,15315,646Mar 07 09:00 PM
Farrington ThomasEVP and CIOMar 05 '24Option Exercise27.261,69346,1514,516Mar 07 08:49 PM
Andersen SvendEVP & President CHCIMar 05 '24Option Exercise27.263,41192,98472,152Mar 07 08:31 PM
Willis RobertEVP & CHROFeb 29 '24Buy25.876,000155,22025,105Mar 01 02:31 PM
Willis RobertEVP & CHROMar 01 '24Buy26.303719,75725,476Mar 01 02:31 PM
Lockwood-Taylor PatrickCEOFeb 29 '24Buy26.549,500252,16820,500Feb 29 01:39 PM
Willis RobertEVP & CHRONov 24 '23Buy31.015,550172,10619,105Nov 27 07:12 PM
Ives AlisonEVP & Chief Scientific OfficerNov 16 '23Buy29.342,04059,85410,380Nov 17 06:03 AM
Bezerra Eduardo GuaritaEVP & Chief Financial OfficerNov 14 '23Buy29.185,000145,8828,428Nov 15 12:14 PM
Lockwood-Taylor PatrickCEONov 14 '23Buy28.9911,000318,86811,000Nov 14 07:12 PM